Nitric Oxide-Derived Oxidants with a Focus on Peroxynitrite: Molecular Targets, Cellular Responses and Therapeutic Implications

被引:130
作者
Calcerrada, P. [1 ,2 ]
Peluffo, G. [1 ,2 ]
Radi, R. [1 ,2 ]
机构
[1] Univ Republica, Dept Bioquim, Fac Med, Montevideo 11800, Uruguay
[2] Univ Republica, Ctr Free Rad & Biomed Res, Fac Med, Montevideo 11800, Uruguay
关键词
Nitric oxide; peroxynitrite; free radicals; oxidative stress; antioxidants; nitrotyrosine; oxidation; nitration; MANGANESE SUPEROXIDE-DISMUTASE; PROTEIN-TYROSINE NITRATION; LOW-DENSITY-LIPOPROTEIN; ISCHEMIA-REPERFUSION INJURY; ENDOTHELIUM-DEPENDENT VASODILATION; AMYOTROPHIC-LATERAL-SCLEROSIS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; PERMEABLE RADICAL SCAVENGER; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; SUCCINYL-COA-3-OXOACID COA-TRANSFERASE;
D O I
10.2174/138161211798357719
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
Nitric oxide participates in a wide array of physiological processes, ranging from neurotransmission to precursor of cytotoxic effector molecules of the immune system. Although nitric oxide is a mildly reactive intermediary, it can act as a precursor of strong oxidants under pathological conditions associated with oxidative stress including cardiovascular, inflammatory and neurodegenerative disorders. Peroxynitrite, the reaction product of nitric oxide with superoxide radicals, emerges as one of the principal players of nitric oxide-derived toxicity due to its facile formation and ability to react with several critical cellular targets including, thiols, proteins, lipids and DNA. The extent of "nitroxidative stress" is determined by several factors, including the concentration and exposure time to this reactive species or its derived radicals and by the ability of the cell to face the oxidative challenge by means of its antioxidant defenses. The inflicted biomolecular damage can result on minimal and reversible changes to cell and tissue physiology, to alteration in bioenergetics, disruption of DNA integrity, mitochondrial dysfunction and even cell death. Although dissecting the free radical chemistry pathways responsible of cell/tissue disturbance of oxidative signaling and promotion of oxidative damage arising from nitric oxide-derived oxidants in a biological context is a vast endeavor, is an ineludible task in order to generate a rational therapeutic approach to modulate nitroxidative stress. Several redox-based pharmacological strategies with a collection of compounds with varying mechanisms of action have been tested at the cellular, preclinical and even clinical levels, and some novel and promising developments are underway. This review deals with key kinetic and biochemical aspects of nitric oxide-derived oxidant formation and reactions in biological systems, emphasizing the current evidence at the biochemical, cell/tissue and animal/human levels that support a pathophysiological role for peroxynitrite and related species in human pathology. In addition, a selection of available pharmacological tools will be discussed as an effort to rationalize antioxidant and/or redox-based therapeutic interventions in disease models.
引用
收藏
页码:3905 / 3932
页数:28
相关论文
共 446 条
[1]
Antioxidant improves smooth muscle sarco/endoplasmic reticulum Ca2+-ATPase function and lowers tyrosine nitration in hypercholesterolemia and improves nitric oxide-induced relaxation [J].
Adachi, T ;
Matsui, R ;
Xu, SQ ;
Kirber, M ;
Lazar, HL ;
Sharov, VS ;
Schöneich, C ;
Cohen, RA .
CIRCULATION RESEARCH, 2002, 90 (10) :1114-1121
[2]
Adachi T, 2010, ADV PHARMACOL, V59, P165, DOI 10.1016/S1054-3589(10)59006-9
[3]
Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury [J].
Adlam, VJ ;
Harrison, JC ;
Porteous, CM ;
James, AM ;
Smith, RAJ ;
Murphy, MP ;
Sammut, IA .
FASEB JOURNAL, 2005, 19 (09) :1088-1095
[4]
GW274150 and GW273629 are potent and highly selective inhibitors of inducible nitric oxide synthase in vitro and in vivo [J].
Alderton, WK ;
Angell, ADR ;
Craig, C ;
Dawson, J ;
Garvey, E ;
Moncada, S ;
Monkhouse, J ;
Rees, D ;
Russell, LJ ;
Russell, RJ ;
Schwartz, S ;
Waslidge, N ;
Knowles, RG .
BRITISH JOURNAL OF PHARMACOLOGY, 2005, 145 (03) :301-312
[5]
Nitric oxide synthases: structure, function and inhibition [J].
Alderton, WK ;
Cooper, CE ;
Knowles, RG .
BIOCHEMICAL JOURNAL, 2001, 357 (03) :593-615
[6]
Classical Inhibitors of NOX NAD(P) H Oxidases Are Not Specific [J].
Aldieri, Elisabetta ;
Riganti, Chiara ;
Polimeni, Manuela ;
Gazzano, Elena ;
Lussiana, Cristina ;
Campia, Ivana ;
Ghigo, Dario .
CURRENT DRUG METABOLISM, 2008, 9 (08) :686-696
[7]
Peroxynitrite reactivity with amino acids and proteins [J].
Alvarez, B ;
Radi, R .
AMINO ACIDS, 2003, 25 (3-4) :295-311
[8]
Alvarez MN, 2002, METHOD ENZYMOL, V359, P353
[9]
Mitochondrial nitric oxide metabolism in rat muscle during endotoxemia [J].
Alvarez, S ;
Boveris, A .
FREE RADICAL BIOLOGY AND MEDICINE, 2004, 37 (09) :1472-1478
[10]
The URICO-ICTUS study, a phase 3 study of combined treatment with uric acid and rtPA administered intravenously in acute ischaemic stroke patients within the first 4•5 h of onset of symptoms [J].
Amaro, Sergio ;
Canovas, David ;
Castellanos, Mar ;
Gallego, Jaime ;
Marti-Fabregas, Joan ;
Segura, Tomas ;
Chamorro, Angel .
INTERNATIONAL JOURNAL OF STROKE, 2010, 5 (04) :325-328